Prior Use of Calcium Channel Blockers Is Associated with Decreased Mortality in Critically Ill Patients with Sepsis: A Prospective Observational Study

Critical Care Medicine

Volumn 45, Issue 3, 2017, Pages 454-463

  Wiewel, Maryse A ^a   Van Vught, Lonneke A ^a   Scicluna, Brendon P ^a   Hoogendijk, Arie J ^a   Frencken, Jos F ^b   Zwinderman, Aeilko H ^a   Horn, Janneke ^a   Cremer, Olaf L ^b   Bonten, Marc J ^b   Schultz, Marcus J ^a   Van Der Poll, Tom ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

calcium channel blockers; intensive care units; mortality; sepsis

Indexed keywords

AMLODIPINE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT; ANTITHROMBIN; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CORTICOSTEROID; CYTOKINE; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FELODIPINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; LERCANIDIPINE; MEPIRODIPINE; NIFEDIPINE; NONSTEROID ANTIINFLAMMATORY AGENT; ORAL ANTIDIABETIC AGENT; PROSTAGLANDIN SYNTHASE INHIBITOR; VERAPAMIL; BIOLOGICAL MARKER; INTERLEUKIN 6; INTERLEUKIN 8; PROTEIN C;

ABDOMINAL INFECTION; AGED; ARTICLE; BLOOD CLOTTING; CRITICALLY ILL PATIENT; DISEASE SEVERITY; FEMALE; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE UNIT; LUNG INFECTION; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; MORTALITY; MULTICENTER STUDY; NETHERLANDS; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PATHOGENESIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEPSIS; SURVIVAL; TERTIARY CARE CENTER; URINARY TRACT INFECTION; VASCULAR ENDOTHELIUM; APACHE; BLOOD; CLINICAL TRIAL; CRITICAL ILLNESS; METABOLISM; MIDDLE AGED; PROPENSITY SCORE;

AGED; ANTITHROMBINS; APACHE; BIOMARKERS; CALCIUM CHANNEL BLOCKERS; CRITICAL ILLNESS; FEMALE; HUMANS; INTENSIVE CARE UNITS; INTERLEUKIN-6; INTERLEUKIN-8; MALE; MIDDLE AGED; PROPENSITY SCORE; PROSPECTIVE STUDIES; PROTEIN C; SEPSIS;

EID: 85009414608     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0000000000002236     Document Type: Article

References (46)

1. Angus DC, van der Poll T: Severe sepsis and septic shock. N Engl J Med 2013; 369:840-851
2. Liu V, Escobar GJ, Greene JD, et al: Hospital deaths in patients with sepsis from 2 independent cohorts. JAMA 2014; 312:90-92
3. Vincent JL, Rello J, Marshall J, et al; EPIC II Group of Investigators: International study of the prevalence and outcomes of infection in intensive care units. JAMA 2009; 302:2323-2329
4. Martin GS, Mannino DM, Eaton S, et al: The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003; 348:1546-1554
5. James PA, Oparil S, Carter BL, et al: 2014 evidence-based guideline for the management of high blood pressure in adults: Report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA 2014; 311:507-520
6. Fihn SD, Gardin JM, Abrams J, et al; American College of Cardiology Foundation; American Heart Association Task Force on Practice Guidelines; American College of Physicians; American Association for Thoracic Surgery; Preventive Cardiovascular Nurses Association; Society for Cardiovascular Angiography and Interventions; Society of Thoracic Surgeons: 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the diagnosis and management of patients with stable ischemic heart disease: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol 2012; 60:e44-e164
7. Braunwald E: Mechanism of action of calcium-channel-blocking agents. N Engl J Med 1982; 307:1618-1627
8. Mason RP, Marche P, Hintze TH: Novel vascular biology of thirdgeneration L-type calcium channel antagonists: Ancillary actions of amlodipine. Arterioscler Thromb Vasc Biol 2003; 23:2155-2163
9. Hotchkiss RS, Karl IE: Calcium: A regulator of the inflammatory response in endotoxemia and sepsis. New Horiz 1996; 4:58-71
10. Dong Z, Saikumar P, Weinberg JM, et al: Calcium in cell injury and death. Annu Rev Pathol 2006; 1:405-434
11. Clapham DE: Calcium signaling. Cell 2007; 131:1047-1058
12. Bosson S, Kuenzig M, Schwartz SI: Verapamil improves cardiac function and increases survival in canine E. coli endotoxin shock. Circ Shock 1985; 16:307-316
13. Wyska E: Pretreatment with R(+)-verapamil significantly reduces mortality and cytokine expression in murine model of septic shock. Int Immunopharmacol 2009; 9:478-490
14. Song SK, Karl IE, Ackerman JJ, et al: Increased intracellular Ca2+: A critical link in the pathophysiology of sepsis? Proc Natl Acad Sci U S A 1993; 90:3933-3937
15. Bosson S, Kuenzig M, Schwartz SI: Increased survival with calcium antagonists in antibiotic-treated bacteremia. Circ Shock 1986; 19:69-74
16. Klein Klouwenberg PM, Ong DS, Bos LD, et al: Interobserver agreement of centers for disease control and prevention criteria for classifying infections in critically ill patients. Crit Care Med 2013; 41:2373-2378
17. Scicluna BP, Klein Klouwenberg PM, van Vught LA, et al: A molecular biomarker to diagnose community-acquired pneumonia on intensive care unit admission. Am J Respir Crit Care Med 2015; 192:826-835
18. Kaukonen KM, Bailey M, Suzuki S, et al: Mortality related to severe sepsis and septic shock among critically ill patients in Australia and New Zealand, 2000-2012. JAMA 2014; 311:1308-1316
19. Bellomo R, Ronco C, Kellum JA, et al. Acute renal failure-definition, outcome measures, animal models, fluid therapy and information technology needs: The Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004; 8:R204-R212
20. Ranieri VM, Rubenfeld GD, Thompson BT, et al; ARDS Definition Task Force: Acute respiratory distress syndrome: The Berlin Definition. JAMA 2012; 307:2526-2533
21. Garner JS, Jarvis WR, Emori TG, et al: CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988; 16:128-140
22. Calandra T, Cohen J: The International Sepsis Forum Consensus Conference on Definitions of Infection in the Intensive Care Unit. Crit Care Med 2005; 33:1538-1548
23. Levy MM, Fink MP, Marshall JC, et al: 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Intensive Care Med 2003; 29:530-538
24. Rubin DB: Estimating causal effects from large data sets using propensity scores. Ann Intern Med 1997; 127:757-763
25. Parlato M, Cavaillon JM: Host response biomarkers in the diagnosis of sepsis: A general overview. Methods Mol Biol 2015; 1237:149-211
26. Liappis AP, Kan VL, Rochester CG, et al: The effect of statins on mortality in patients with bacteremia. Clin Infect Dis 2001; 33: 1352-1357
27. Meldrum DR, Ayala A, Perrin MM, et al: Diltiazem restores IL-2, IL-3, IL-6, and IFN-gamma synthesis and decreases host susceptibility to sepsis following hemorrhage. J Surg Res 1991; 51:158-164
28. Szabó C, Haskó G, Németh ZH, et al: Calcium entry blockers increase interleukin-10 production in endotoxemia. Shock 1997; 7:304-307
29. Hotchkiss RS, Osborne DF, Lappas GD, et al: Calcium antagonists decrease plasma and tissue concentrations of tumor necrosis factoralpha, interleukin-1 beta, and interleukin-1 alpha in a mouse model of endotoxin. Shock 1995; 3:337-342
30. Hotchkiss RS, Karl IE: Dantrolene ameliorates the metabolic hallmarks of sepsis in rats and improves survival in a mouse model of endotoxemia. Proc Natl Acad Sci U S A 1994; 91:3039-3043
31. Brovkovych V, Kalinowski L, Muller-Peddinghaus R, et al: Synergistic antihypertensive effects of nifedipine on endothelium: Concurrent release of NO and scavenging of superoxide. Hypertension 2001; 37:34-39
32. Lo CJ, Garcia I, Cryer HG, et al: Calcium and calmodulin regulate lipopolysaccharide-induced alveolar macrophage production of tumor necrosis factor and procoagulant activity. Arch Surg 1996; 131: 44-50
33. Sayeed MM, Maitra SR: Effect of diltiazem on altered cellular calcium regulation during endotoxic shock. Am J Physiol 1987; 253:R549-R554
34. Meldrum DR, Ayala A, Chaudry IH: Mechanism of diltiazem's immunomodulatory effects after hemorrhage and resuscitation. Am J Physiol 1993; 265:C412-C421
35. Duchen MR: Mitochondria and calcium: From cell signalling to cell death. J Physiol 2000; 529 Pt 1:57-68
36. Zhu X, Bernecker OY, Manohar NS, et al: Increased leakage of sarcoplasmic reticulum Ca2+ contributes to abnormal myocyte Ca2+ handling and shortening in sepsis. Crit Care Med 2005; 33:598-604
37. Mortensen EM, Nakashima B, Cornell J, et al: Population-based study of statins, angiotensin II receptor blockers, and angiotensin-converting enzyme inhibitors on pneumonia-related outcomes. Clin Infect Dis 2012; 55:1466-1473
38. Mortensen EM, Pugh MJ, Copeland LA, et al: Impact of statins and angiotensin-converting enzyme inhibitors on mortality of subjects hospitalised with pneumonia. Eur Respir J 2008; 31:611-617
39. Wu A, Good C, Downs JR, et al: The association of cardioprotective medications with pneumonia-related outcomes. PLoS One 2014; 9:e85797
40. Macchia A, Romero M, Comignani PD, et al: Previous prescription of blockers is associated with reduced mortality among patients hospitalized in intensive care units for sepsis. Crit Care Med 2012; 40:2768-2772
41. Ma Y, Wen X, Peng J, et al: Systematic review and meta-analysis on the association between outpatient statins use and infectious disease-related mortality. PLoS One 2012; 7:e51548
42. Wan YD, Sun TW, Kan QC, et al: Effect of statin therapy on mortality from infection and sepsis: A meta-analysis of randomized and observational studies. Crit Care 2014; 18:R71
43. Wiewel MA, de Stoppelaar SF, van Vught LA, et al; MARS Consortium: Chronic antiplatelet therapy is not associated with alterations in the presentation, outcome, or host response biomarkers during sepsis: A propensity-matched analysis. Intensive Care Med 2016; 42:352-360
44. Tsai MJ, Ou SM, Shih CJ, et al: Association of prior antiplatelet agents with mortality in sepsis patients: A nationwide population-based cohort study. Intensive Care Med 2015; 41:806-813
45. Valerio-Rojas JC, Jaffer IJ, Kor DJ, et al: Outcomes of severe sepsis and septic shock patients on chronic antiplatelet treatment: A historical cohort study. Crit Care Res Pract 2013; 2013:782573
46. Eisen DP, Reid D, McBryde ES: Acetyl salicylic acid usage and mortality in critically ill patients with the systemic inflammatory response syndrome and sepsis. Crit Care Med 2012; 40:1761-1767